labetalol hydrochloride 300 MG Oral Tablet
- RxCUI
- 896766
- RxNorm name
- labetalol hydrochloride 300 MG Oral Tablet
- Display name
- labetalol hydrochloride 300 MG Oral Tablet
- Full name
- labetalol hydrochloride 300 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | BluePoint Laboratories Inc. | 63ede355-42ec-4c52-a941-51e5f6b35ed6 | 2026-06-08 | Warnings, Adverse reactions | 896766 |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | fffb7c59-ad92-4e74-850d-d94d42b7fdc9 | 2026-06-04 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | BluePoint Laboratories | e4562c70-f245-4dbe-8fe1-0bb64a91a315 | 2026-06-04 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cardinal Health 107, LLC | d3ca153c-25b2-4506-91bd-bf9d6a4c01fe | 2026-05-19 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Golden State Medical Supply, Inc. | d5ce687f-4a37-d3e6-e053-2995a90aa974 | 2026-04-16 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | NorthStar Rx LLC | 5bd81a8a-a480-4c8d-bd4f-3158412e6a73 | 2026-04-13 | Warnings, Adverse reactions | 896766 |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 106a0959-5830-489f-ba60-afd4eb0fac36 | 2026-04-02 | Warnings, Adverse reactions | 896766 |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 1c680447-b43a-4ff1-bc64-2c2174ca1c9a | 2026-04-02 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d4364caf-46c6-4144-9ba5-2c561e4f3a95 | 2026-03-26 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | f7f7fade-98a6-4741-bfb9-f1eb54ad4565 | 2026-03-25 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | bf84ebae-3c91-4448-b1db-8e5ed3053866 | 2026-03-05 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Major Pharmaceuticals | 35b5fd32-581d-427b-9a13-b7a02846d21d | 2026-03-03 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 5942a5a8-c3c1-4ecb-921e-9bc92393bdf8 | 2026-03-02 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | ed0188ba-3fd3-4680-a829-ba242a115fab | 2026-02-25 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Biocon Pharma Inc. | 27e4ab03-c17b-4268-912c-e45a5e8f8dd8 | 2026-02-19 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 0db22a64-1863-4188-850b-273ea746e327 | 2026-02-09 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Innogenix, Inc. | 82fc2d64-0572-4a9b-94fc-f6eb8d930c54 | 2025-12-23 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Method Pharmaceuticals, LLC | 733d6e32-ac90-4796-bf25-9d5887c897a5 | 2025-12-23 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Chartwell RX, LLC | ac439c08-1e47-4306-8308-b31d7a1a443c | 2025-12-02 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | dafa7411-2857-4f5a-a587-4367cfbe2bfa | 2025-10-23 | Warnings, Adverse reactions | 896766 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| fffb7c59-ad92-4e74-850d-d94d42b7fdc9 | labetalol HCl 300 MG Oral Tablet [PSN] · labetalol hydrochloride 300 MG Oral Tablet [SCD] | 2 | 1 | Labetalol Hydrochloride Tablets USP Rx only | 20251003 |
| b950655d-a9f8-4ace-bb56-0c7abbca231e | labetalol HCl 300 MG Oral Tablet [PSN] · labetalol hydrochloride 300 MG Oral Tablet [SCD] | 2 | 1 | labetalol hydrochloride tablets, usp | 20210930 |
| b4c13317-88eb-48f2-aba2-50f01c8ff938 | labetalol HCl 300 MG Oral Tablet [PSN] · labetalol hydrochloride 300 MG Oral Tablet [SCD] | 2 | 1 | Labetalol | 20180406 |